Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Clean Vision (CLNV) Liabilities and Shareholders Equity (2023 - 2025)

Clean Vision (CLNV) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $21.7 million as the latest value for Q2 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 108.83% to $21.7 million in Q2 2025 year-over-year; TTM through Sep 2025 was $52.5 million, a 24.49% increase, with the full-year FY2024 number at $13.1 million, up 23.38% from a year prior.
  • Liabilities and Shareholders Equity was $21.7 million for Q2 2025 at Clean Vision, up from $17.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $21.7 million in Q2 2025 to a low of $1.8 million in Q1 2023.
  • A 3-year average of $11.6 million and a median of $10.6 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 500.27% in 2024; the steepest drop was 2.36% in 2024.
  • Clean Vision's Liabilities and Shareholders Equity stood at $10.6 million in 2023, then grew by 23.38% to $13.1 million in 2024, then soared by 66.02% to $21.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLNV's Liabilities and Shareholders Equity are $21.7 million (Q2 2025), $17.7 million (Q1 2025), and $13.1 million (Q4 2024).